Drug interactions with itraconazole, fluconazole, and terbinafine and their management (Q33699931)

28 July 2017

1 reference

title

Drug interactions with itraconazole, fluconazole, and terbinafine and their management (English)

1 reference

28 July 2017

0 references

1 reference

Gupta AK

1

1 reference

28 July 2017

Katz HI

series ordinal

2

1 reference

28 July 2017

Shear NH

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

Journal of the American Academy of Dermatology

28 July 2017

published in

1 reference

28 July 2017

volume

41

1 reference

28 July 2017

issue

2 Pt 1

1 reference

28 July 2017

page(s)

237-249

1 reference

Antifungal agents: an overview. Part II.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Recent Advances: the Cytochrome P450 Enzymes

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The P450 gene superfamily: recommended nomenclature

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Cytochrome P-450 3A: Interactions with dermatologic therapies

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole?

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The mechanism of the interaction between amiodarone and warfarin in humans

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of Food Intake on the Bioavailability of Itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of oral antacid administration on the pharmacokinetics of oral fluconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The influence of gastric acidity on the bio-availability of ketoconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Clinical pharmacokinetics of ketoconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Possible interaction between phenobarbital, carbamazepine and itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Influence of itraconazole on the pharmacokinetics and electrocardiographic effects of astemizole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Torsades de pointes after terfenadine-itraconazole interaction

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole and anti-tuberculosis drugs

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Uveitis associated with rifabutin prophylaxis and itraconazole therapy

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The effect of ingestion time interval on the interaction between itraconazole and triazolam

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Lack of effect of antimycotic itraconazole on the pharmacokinetics or pharmacodynamics of temazepam

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The effect of the antimycotic itraconazole on the pharmacokinetics and pharmacodynamics of diazepam

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole*

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole interacts with felodipine

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole greatly increases plasma concentrations and effects of felodipine.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction of cyclosporin and itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole and cyclosporin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Cyclosporine and itraconazole interaction in heart and lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction of cyclosporin and itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole-Digoxin Interaction

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction of itraconazole and digoxin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction between itraconazole and digoxin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Digoxin toxicity associated with itraconazole therapy

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Digoxin-itraconazole interaction

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole increases serum digoxin concentration

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole Decreases Renal Clearance of Digoxin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Comment: Possible Mechanism of Digoxin–Itraconazole Interaction

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Probable interaction between fluoxetine and itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Drug-interaction-induced rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Adrenal response to corticotropin during therapy with itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

In-vivo effects of itraconazole on hepatic mixed-function oxidase

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Gliclazide hydroxylation by rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metabolite

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Itraconazole increases plasma concentrations of quinidine*

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction Between Tacrolimus and Itraconazole in a Heart–Lung Transplant Recipient

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Vincristine toxicity in five children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Potentiation of action of warfarin by itraconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

A fluconazole/amitriptyline drug interaction in three male adults

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Fluconazole-nortriptyline drug interaction

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of fluconazole on pharmacokinetics of 2',3'-dideoxyinosine in persons seropositive for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Induction of fluconazole metabolism by rifampin: in vivo study in humans.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction between fluconazole and rifampicin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Rifampin-fluconazole interaction in critically ill patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Lack of effect of fluconazole on the pharmacokinetics of rifampicin in AIDS patients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Fluconazole and Enhanced Effect of Rifabutin Prophylaxis

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Fluconazole-cyclosporine interaction: a dose-dependent effect?

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

INTERACTION OF FLUCONAZOLE WITH CYCLOSPORIN

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction of fluconazole with cyclosporin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Absence of significant interaction of fluconazole with cyclosporin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction of Fluconazole with Ciclosporin A

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

INTERACTION BETWEEN FLUCONAZOLE AND CYCLOSPORIN

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction of fluconazole and cyclosporine

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction between cyclosporine and fluconazole in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Safety of fluconazole in women taking oral hypoglycaemic agents

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Fluconazole and phenytoin: a predictable interaction

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Fluconazole-induced symptomatic phenytoin toxicity

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Drug interactions with fluconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of fluconazole on the disposition of phenytoin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Drug interactions with fluconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Cytochrome P450 isozymes and antiepileptic drug interactions

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Fluconazole therapy in transplant recipients receiving FK506.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of fluconazole on theophylline disposition in humans

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Fluconazole-warfarin interaction

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Case report: potentiation of warfarin by fluconazole

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Clinical singgnificance of interactions with antifungal agents

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Azoles, a48 llylamines and drug metabolism

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Medicine taking in Southampton: a second look

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The effects of retinoids and terbinafine on the human hepatic microsomal metabolism of cyclosporin

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Oral antifungal drug interactions

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The antimycotic drug terbinafine in contrast to ketoconazole lacks acute effects on the pituitary-testicular function of healthy men: a placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

In vivo effects of terbinafine and ketoconazole on testosterone plasma levels in healthy males

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Antipyrine metabolism is not affected by terbinafine, a new antifungal agent

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of Terbinafine on the Pharmacokinetics of Cyclosporin in Humans

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

The use of caffeine for enzyme assays: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Absence of effect of terbinafine on the activity of CYP1A2, NAT-2, and xanthine oxidase.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Effect of terbinafine on theophylline pharmacokinetics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Drug points: Serious interaction between warfarin and oral terbinafine

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

Interaction between terbinafine and warfarin.

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(99)70055-1

7 January 2021

10.1016/S0190-9622(99)70055-1

Identifiers

DOI

1 reference

release_hp63suh5wfcbjawfzs52ao3gju

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hp63suh5wfcbjawfzs52ao3gju

24 November 2022

mapped directly with Wikidata item

1 reference